Logotype for Leap Therapeutics Inc

Leap Therapeutics (LPTX) investor relations material

Leap Therapeutics Q2 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Leap Therapeutics Inc
Q2 2025 earnings summary14 Aug, 2025

Executive summary

  • Reported updated clinical data from the DeFiance study showing statistically significant benefits for sirexatamab in certain colorectal cancer patient subgroups; final data to be presented at a future conference.

  • Initiated a process to explore strategic alternatives, including potential sale, partnership, or merger, and engaged a financial advisor to assist.

  • Implemented a workforce reduction of 75% to conserve cash and focus on corporate development, with estimated total costs of $4.5 million.

  • Completed patient treatment in the DeFiance trial.

Financial highlights

  • Net loss attributable to common stockholders was $16.6 million for Q2 2025, compared to $20.4 million in Q2 2024.

  • Net loss per share was $0.40 for Q2 2025, compared to $0.52 for Q2 2024.

  • Cash and cash equivalents were $18.1 million as of June 30, 2025, down from $47.2 million at December 31, 2024.

  • Research and development expenses decreased to $10.5 million in Q2 2025 from $17.9 million in Q2 2024.

  • General and administrative expenses fell to $1.8 million from $3.4 million year-over-year.

Outlook and guidance

  • Substantial doubt exists regarding the ability to continue as a going concern for at least the next 12 months without additional capital or a strategic transaction.

  • Board is exploring all strategic alternatives, including merger, asset sale, or additional funding, but no assurance of successful completion.

  • Further updates on the strategic review are expected in the coming weeks.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Leap Therapeutics earnings date

Logotype for Leap Therapeutics Inc
Q3 202513 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Leap Therapeutics earnings date

Logotype for Leap Therapeutics Inc
Q3 202513 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Leap Therapeutics Inc. is a clinical-stage biopharmaceutical company that focuses on developing novel therapeutics for cancer treatment. The company's main activities involve acquiring and developing antibody therapies, particularly targeting cancer-specific pathways and cell surface molecules, while also activating the immune system against cancer cells. Leap Therapeutics is engaged in multiple ongoing clinical trials for its lead product candidates. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage